Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contribution of uric acid to cancer risk, recurrence, and mortality
Mehdi A. Fini, A. Elias, Richard J. Johnson, et al.
Clinical and Translational Medicine (2012) Vol. 1, Iss. 1
Open Access | Times Cited: 216

Showing 1-25 of 216 citing articles:

The role of uric acid in the pathogenesis of human cardiovascular disease
Mehmet Kanbay, Mark S. Segal, Barış Afşar, et al.
Heart (2013) Vol. 99, Iss. 11, pp. 759-766
Closed Access | Times Cited: 416
Damage-associated molecular patterns in cancer: a double-edged sword
Claudia Hernandez, Peter Huebener, Robert F. Schwabe
Oncogene (2016) Vol. 35, Iss. 46, pp. 5931-5941
Open Access | Times Cited: 405
Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia
Georgiana Cabău, Tania O. Crişan, Viola Klück, et al.
Immunological Reviews (2019) Vol. 294, Iss. 1, pp. 92-105
Open Access | Times Cited: 195
The role of xanthine oxidoreductase and uric acid in metabolic syndrome
Maria Giulia Battelli, Massimo Bortolotti, Letizia Polito, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1864, Iss. 8, pp. 2557-2565
Open Access | Times Cited: 178
U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia
William T. Crawley, Cyprien G. Jungels, Kurt R. Stenmark, et al.
Redox Biology (2022) Vol. 51, pp. 102271-102271
Open Access | Times Cited: 127
Cancer risk associated with chronic diseases and disease markers: prospective cohort study
Huakang Tu, Chi Pang Wen, Shan P. Tsai, et al.
BMJ (2018), pp. k134-k134
Open Access | Times Cited: 153
U‐Shaped Association Between Serum Uric Acid Level and Risk of Mortality
Sung Kweon Cho, Yoosoo Chang, Inah Kim, et al.
Arthritis & Rheumatology (2018) Vol. 70, Iss. 7, pp. 1122-1132
Closed Access | Times Cited: 139
Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets
Franklyn De Silva, Jane Alcorn
Pharmaceuticals (2019) Vol. 12, Iss. 2, pp. 68-68
Open Access | Times Cited: 135
Xanthine oxidoreductase in cancer: more than a differentiation marker
Maria Giulia Battelli, Letizia Polito, Massimo Bortolotti, et al.
Cancer Medicine (2015) Vol. 5, Iss. 3, pp. 546-557
Open Access | Times Cited: 129
Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase
Maria Giulia Battelli, Massimo Bortolotti, Letizia Polito, et al.
Redox Biology (2018) Vol. 21, pp. 101070-101070
Open Access | Times Cited: 104
Impaired intestinal barrier function in a mouse model of hyperuricemia
Yingjie Guo, Hailong Li, Zhen Liu, et al.
Molecular Medicine Reports (2019)
Open Access | Times Cited: 84
Breast Cancer Diagnosis by Surface-Enhanced Raman Scattering (SERS) of Urine
Vlad Moisoiu, Andreea Iulia Socaciu, Andrei Ştefancu, et al.
Applied Sciences (2019) Vol. 9, Iss. 4, pp. 806-806
Open Access | Times Cited: 77
The Good, the Bad and the New about Uric Acid in Cancer
S. Allegrini, Mercedes Garcia‐Gil, Rossana Pesi, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4959-4959
Open Access | Times Cited: 44
Serum Uric Acid Increases Risk of Cancer Incidence and Mortality: A Systematic Review and Meta‐Analysis
Shushan Yan, Pengjun Zhang, Wei Xu, et al.
Mediators of Inflammation (2015) Vol. 2015, Iss. 1
Open Access | Times Cited: 75
Feasibility of Detecting Prostate Cancer by Ultraperformance Liquid Chromatography–Mass Spectrometry Serum Metabolomics
Xiaoling Zang, Christina M. Jones, Long Tran Quoc, et al.
Journal of Proteome Research (2014) Vol. 13, Iss. 7, pp. 3444-3454
Open Access | Times Cited: 69
<p>Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications</p>
Min Gong, Song Wen, Thiquynhnga Nguyen, et al.
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 943-962
Open Access | Times Cited: 66
Deoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease
Raquel Buj, Katherine M. Aird
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 65
Emerging Role of Purine Metabolizing Enzymes in Brain Function and Tumors
Mercedes Garcia‐Gil, Marcella Camici, S. Allegrini, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3598-3598
Open Access | Times Cited: 65
Global and targeted serum metabolic profiling of colorectal cancer progression
Yin Long, Beatriz Sánchez‐Espiridión, Moubin Lin, et al.
Cancer (2017) Vol. 123, Iss. 20, pp. 4066-4074
Open Access | Times Cited: 63
Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study
Iris J. M. Disveld, Sahel Zoakman, Tim Jansen, et al.
Clinical Rheumatology (2019) Vol. 38, Iss. 5, pp. 1385-1391
Closed Access | Times Cited: 59
Serum uric acid levels and cancer mortality risk among males in a large general population-based cohort study
Niloofar Taghizadeh, Judith M. Vonk, H. Marike Boezen
Cancer Causes & Control (2014) Vol. 25, Iss. 8, pp. 1075-1080
Open Access | Times Cited: 64
What Are the Key Arguments Against Uric Acid as a True Risk Factor for Hypertension?
Richard J. Johnson, Laura Gabriela Sánchez‐Lozada, Marilda Mazzali, et al.
Hypertension (2013) Vol. 61, Iss. 5, pp. 948-951
Open Access | Times Cited: 63
Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study
Andrew Yiu, Mieke Van Hemelrijck, Hans Garmo, et al.
Oncotarget (2017) Vol. 8, Iss. 26, pp. 42332-42342
Open Access | Times Cited: 61
Targeting roles of inflammatory microenvironment in lung cancer and metastasis
Lin Shi, Lingyan Wang, Jiayan Hou, et al.
Cancer and Metastasis Reviews (2015) Vol. 34, Iss. 2, pp. 319-331
Closed Access | Times Cited: 57
Insight into rheumatological cause and effect through the use of Mendelian randomization
Philip C. Robinson, Hyon K. Choi, Ron Do, et al.
Nature Reviews Rheumatology (2016) Vol. 12, Iss. 8, pp. 486-496
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top